Xue Wu

Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients

Zhe Yang, Nong Yang, Qiuxiang Ou et al. · Clinical Cancer Research · 2018 · 531 citations

Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types

Yongqian Shu, Xue Wu, Xiaoling Tong et al. · Scientific Reports · 2017 · 256 citations · Full text

Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti–PD-(L)1 Therapies in Non–Small Cell Lung Cancer

Wenfeng Fang, Yuxiang Ma, Jiani C. Yin et al. · Clinical Cancer Research · 2019 · 235 citations

Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer

De‐Shen Wang, Zexian Liu, Yun-Xin Lu et al. · Gut · 2018 · 192 citations

Atorvastatin Coadministration May Increase Digoxin Concentrations by Inhibition of Intestinal P-Glycoprotein-Mediated Secretion

Rebecca A. Boyd, R. H. Stern, Barbra H. Stewart et al. · The Journal of Clinical Pharmacology · 2000 · 172 citations

Inflammation, Molecular Pharmacology, Intestinal P-glycoprotein-mediated Secretion +14